merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The ruling casts a shadow on her leadership and could make it harder to secure votes.</answer>
<question_number>2</question_number>
<answer>Concerns about lack of transparency on vaccine contracts, which come amid a recent surge in far-right politicians gaining seats in the European Parliament, have contributed to a sense of distrust among European voters about how officials have spent taxpayer money.</answer>
<question_number>3</question_number>
<answer>She will need votes from center-left lawmakers including the Greens, who have been incensed by the way she handled the coronavirus crisis.</answer>
<question_number>4</question_number>
<answer>Concerns about the lack of transparency on the vaccine contracts, which come amid a recent surge in far-right politicians gaining seats in the European Parliament, have contributed to a sense of distrust among European voters about how officials have spent taxpayer money.</answer>
<question_number>5</question_number>
<answer>N/A</answer>
<question_number>6</question_number>
<answer>It came just ahead of what is expected to be a tight vote on Thursday that will determine if she will serve another term as the European Union's top official.</answer>
<question_number>7</question_number>
<answer>The European Union's initial vaccine campaign was marred by a slow start compared with Britain and the United States, with the bloc taking a more conservative, budget-conscious approach. But the European Union later caught up and even surpassed other major countries after Ms. von der Leyen secured a contract with Pfizer-BioNTech.</answer>
<question_number>8</question_number>
<answer>The European Commission said in a statement that it would "carefully study" the court's findings and their implications. It noted that the commission had needed to "strike a difficult balance" between giving the public and members of the European Parliament access to information, while satisfying the legal requirements of the vaccine contracts.</answer>
<question_number>9</question_number>
<answer>The New York Times last year sued the European Commission as part of a freedom of information request that sought access to text messages between Ms. von der Leyen and the chief executive of Pfizer, Albert Bourla, as they negotiated a deal for Covid-19 vaccines. The case is pending in the European Court of Justice.</answer>
<question_number>10</question_number>
<answer>N/A</answer>